
Vivogesic AQ 75mg Injection
Marketer
BestoChem Formulations India Ltd
Salt Composition
Diclofenac (75mg)
Overview Vivogesic AQ 75mg Injection
Arthrogesic 75mg Injection provides analgesia. Indicated for pain, inflammation, rigidity, and arthralgia associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma when oral medication is unsuitable. Administration is strictly by a healthcare provider via injection; self-administration is prohibited. Prior heart disease or stroke history should be disclosed to your physician. Report any injection site reactions (pain, swelling, erythema) immediately. Common adverse effects include nausea, emesis, cephalgia, and injection site reactions. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with blood counts. Chronic use carries a risk of serious complications, including gastrointestinal bleeding and nephropathy.
Uses of Vivogesic AQ 75mg Injection
Analgesia
Major Benefits of Vivogesic AQ 75mg Injection:
Administering this medication will be handled by your physician or registered nurse; patient self-medication is strictly prohibited.
Common Side effects of Vivogesic AQ 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Vivogesic AQ 75mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vivogesic AQ 75mg Injection works:
A single dose of 75mg Vivogesic AQ injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators, thereby reducing pain and associated swelling and redness.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Vivogesic AQ 75mg Injection alongside alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Vivogesic AQ 75mg Injection during pregnancy carries a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Vivogesic AQ 75mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administration of Vivogesic AQ 75mg Injection may induce adverse reactions potentially impairing driving capabilities.
KidneyCAUTION
For individuals with kidney impairment, administration of Vivogesic AQ 75mg Injection requires careful consideration. Dosage modification of Vivogesic AQ 75mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, the administration of Vivogesic AQ 75mg Injection requires careful monitoring. Dosage modification of Vivogesic AQ 75mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Vivogesic AQ 75mg Injection :
Omit a Vivogesic AQ 75mg Injection dose? Seek medical advice.
Facts to Know About Vivogesic AQ 75mg Injection
| Label | Value |
|---|---|
| Type of Compound | Derivative of phenylacetic acid |
| Potential for Dependence | None. |
| Type of Medication | Medications for Pain Relief |
